Search Tag: CytoSorbents

ICU Management

CytoSorbents Expands Direct Sales of CytoSorb to Belgium and Luxembourg

2016 04 Nov

CytoSorbents Corporation(NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® extracorporeal cytokine adsorber to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced the addition of Belgium and Luxembourg to its direct sales territories.  CytoSorb is now distributed... Read more

ICU Management

CytoSorbents Announces 26th Symposium for Intensive Medicine & Intensive Care Agenda in Bremen

2016 18 Feb

CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced its agenda for the 26th Symposium for Intensive Medicine + Intensive Care in Bremen, Germany from February 24-26, 2016.As the... Read more

ICU Management

CytoSorbents Reports Steady Growth in Q2 2015

2015 14 Aug

CytoSorbents Corporation, a critical care immunotherapy leader commercialising its CytoSorb® blood purification technology to reduce deadly uncontrolled inflammation in hospitalised patients around the world, reported financial and operational results for the three and six months ended June 30, 2015. Recent Financial Highlights:Product revenues for... Read more

ICU Management

ISICEM 2014: CytoSorbents to Sponsor CytoSorb® Research Symposium

2014 14 Mar

CytoSorbents Corporation, a critical care immunotherapy company using blood purification to treat life-threatening illnesses in the intensive care unit, announced that it will sponsor a research symposium entitled:"SIRS and SEPSIS – New Therapy with CytoSorb®" at the 34th International Symposium on Intensive Care and Emergency Medicine (ISICEM 2014)... Read more


Endorsed Companies